Table 2 Fluorescent antibody panel for the 2002 Haughton Mars Immune Assessment
From: Immune system changes during simulated planetary exploration on Devon Island, high arctic
FITC | PE | ECD | PE/Cy5 | APC | CELL POPULATIONS |
|---|---|---|---|---|---|
CD14 (RMO52) | Â | Â | CD45 (J.33) | Â | WBC differential: granulocytes/lymphocytes/monocytes |
CD3 (UCHT1) | CD16 (3G8) | CD19 (J4.119) | CD45 (J.33) | Â | Lymphocyte subsets: T cells, B cells and NK cells |
CD4 (13B8.2) | CD8 (B9.11) | Â | CD3 (UCHT1) | Â | T cell subsets: CD4+ vs. CD8+ |
CD45RA (ALB11) | CD45RO (UCHL1) |  | CD4 (13B8.2) | CD3 (UCHT1) | Naïve/memory CD4+ T cell subsets |
CD45RA (ALB11) | CD45RO (UCHL1) |  | CD8 (B9.11) | CD3 (UCHT1) | Naïve/memory CD8+ T cell subsets |
CD8 (B9.11) | CD28 (CD28.2) | Â | CD244 (C1.7) | CD3 (UCHT1) | Cytotoxic effector/suppressor CD8+ T cell subsets |
HLA-DR (Immu-357) | CD69 (TP1.55.3) | CD8 (B9.11) | CD4 (13B8.2) | CD3 (UCHT1) | Activation status of T cell subsets (CD4/CD8+) |
IFNg* (5344.111) | IL-2* (25723.11) | CD8 (B9.11) | CD3 (UCHT1) | Â | Intracellular detection of cytokines in T cell subsets |